Proposed achievable levels of dose and impact of dose-reduction systems for thrombectomy in acute ischemic stroke: an international, multicentric, retrospective study in 1096 patients.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 14 11 2018
accepted: 01 02 2019
revised: 08 01 2019
pubmed: 25 3 2019
medline: 27 8 2019
entrez: 24 3 2019
Statut: ppublish

Résumé

International dose reference levels are lacking for mechanical thrombectomy in acute ischemic stroke patients with large vessel occlusions. We studied whether radiation dose-reduction systems (RDS) could effectively reduce exposure and propose achievable levels. We retrospectively included consecutive patients treated with thrombectomy on a biplane angiography system (BP) in five international, high-volume centers between January 2014 and May 2017. Institutional Review Board approvals were obtained. Technical, procedural, and clinical characteristics were assessed. Efficacy, safety, radiation dose, and contrast load were compared between angiography systems with and without RDS. Multivariate analyses were adjusted according to Bonferroni's correction. Proposed international achievable cutoff levels were set at the 75th percentile. Out of the 1096 thrombectomized patients, 520 (47%) were treated on a BP equipped with RDS. After multivariate analysis, RDS significantly reduced dose-area product (DAP) (91 vs 140 Gy cm Radiation dose-reduction systems can reduce DAP and air kerma by a third and a half, respectively, without affecting thrombectomy efficacy or safety. The respective thresholds of 148 Gy cm • Internationally validated achievable levels may help caregivers and health authorities better assess and reduce radiation exposure of both ischemic stroke patients and treating staff during thrombectomy procedures. • Radiation dose-reduction systems can reduce DAP and air kerma by a third and a half, respectively, without affecting thrombectomy efficacy or safety in the setting of acute ischemic stroke due to large vessel occlusion.

Sections du résumé

BACKGROUND BACKGROUND
International dose reference levels are lacking for mechanical thrombectomy in acute ischemic stroke patients with large vessel occlusions. We studied whether radiation dose-reduction systems (RDS) could effectively reduce exposure and propose achievable levels.
MATERIALS AND METHODS METHODS
We retrospectively included consecutive patients treated with thrombectomy on a biplane angiography system (BP) in five international, high-volume centers between January 2014 and May 2017. Institutional Review Board approvals were obtained. Technical, procedural, and clinical characteristics were assessed. Efficacy, safety, radiation dose, and contrast load were compared between angiography systems with and without RDS. Multivariate analyses were adjusted according to Bonferroni's correction. Proposed international achievable cutoff levels were set at the 75th percentile.
RESULTS RESULTS
Out of the 1096 thrombectomized patients, 520 (47%) were treated on a BP equipped with RDS. After multivariate analysis, RDS significantly reduced dose-area product (DAP) (91 vs 140 Gy cm
CONCLUSION CONCLUSIONS
Radiation dose-reduction systems can reduce DAP and air kerma by a third and a half, respectively, without affecting thrombectomy efficacy or safety. The respective thresholds of 148 Gy cm
KEY POINTS CONCLUSIONS
• Internationally validated achievable levels may help caregivers and health authorities better assess and reduce radiation exposure of both ischemic stroke patients and treating staff during thrombectomy procedures. • Radiation dose-reduction systems can reduce DAP and air kerma by a third and a half, respectively, without affecting thrombectomy efficacy or safety in the setting of acute ischemic stroke due to large vessel occlusion.

Identifiants

pubmed: 30903333
doi: 10.1007/s00330-019-06062-6
pii: 10.1007/s00330-019-06062-6
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Pagination

3506-3515

Références

Radiology. 2015 May;275(2):510-20
pubmed: 25633505
J Neuroradiol. 2019 Jul;46(4):243-247
pubmed: 30030061
Med Phys. 2008 Feb;35(2):673-80
pubmed: 18383689
Neuroradiology. 2013 Nov;55(11):1365-72
pubmed: 24005833
Phys Med Biol. 2000 Dec;45(12):3833-46
pubmed: 11131203
J Vasc Interv Radiol. 2003 Jun;14(6):711-27
pubmed: 12817038
Int J Stroke. 2016 Aug;11(6):701-16
pubmed: 27462090
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Ann ICRP. 2017 Oct;46(1):1-144
pubmed: 29065694
Radiology. 2016 Mar;278(3):962
pubmed: 26885743
Cardiovasc Intervent Radiol. 2009 Jan;32(1):19-24
pubmed: 18931875
Radiology. 2013 Nov;269(2):553-60
pubmed: 23737536
Ann Neurol. 2018 Oct;84(4):616-620
pubmed: 30168180
Radiology. 2018 Feb;286(2):592-601
pubmed: 29019450
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
J Radiol Prot. 2012 Mar;32(1):N51-4
pubmed: 22394591
Eur Radiol. 2007 Jun;17(6):1621-33
pubmed: 17072616
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Eur Radiol. 2016 Nov;26(11):4184-4193
pubmed: 26852216
N Engl J Med. 2007 Nov 29;357(22):2277-84
pubmed: 18046031
Eur Radiol. 2019 Feb;29(2):645-653
pubmed: 30019142
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2011;67(3):298-301
pubmed: 21471688
AJNR Am J Neuroradiol. 2014 Jul;35(7):1276-80
pubmed: 24627454
J Neurointerv Surg. 2017 Sep;9(9):830-833
pubmed: 27566492
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
BMJ. 2010 Jan 14;340:b5349
pubmed: 20075151
J Neurointerv Surg. 2017 Aug;9(8):722-726
pubmed: 27422968
Stroke. 2015 Oct;46(10):3020-35
pubmed: 26123479
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Br J Radiol. 1995 Oct;68(814):1083-6
pubmed: 7496708
Radiat Prot Dosimetry. 2014 Dec;162(3):316-21
pubmed: 24255172
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Radiology. 2005 May;235(2):354-8
pubmed: 15758190
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Eur Radiol. 2018 Sep;28(9):3669-3675
pubmed: 29651772
EuroIntervention. 2012 Jan;7(9):1081-6
pubmed: 22207231
Eur Radiol. 2017 Sep;27(9):3983-3990
pubmed: 28210801
Ann ICRP. 2001;31(4):33-52
pubmed: 12685758
Stroke. 2013 Sep;44(9):2650-63
pubmed: 23920012
JAMA Neurol. 2017 Jun 1;74(6):695-703
pubmed: 28395017
Radiology. 2009 Dec;253(3):753-64
pubmed: 19789226

Auteurs

Adrien Guenego (A)

Interventional Neuroradiology Department, Hôpital Pierre-Paul Riquet, Toulouse University Hospital, Place du Dr Baylac, TSA 40 031, 31059, Toulouse Cedex 9, France. adrienguenego@gmail.com.

Pascal J Mosimann (PJ)

Interventional and Diagnostic Neuroradiology, Bern, Switzerland.

Vitor Mendes Pereira (VM)

Interventional and Diagnostic Neuroradiology, Toronto Western Hospital, Toronto, Canada.

Patrick Nicholson (P)

Interventional and Diagnostic Neuroradiology, Toronto Western Hospital, Toronto, Canada.

Kevin Zuber (K)

Clinical Research Unit, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Jean Albert Lotterie (JA)

Stereotaxic Neurosurgery Department, Toulouse University Hospital, Toulouse, France.

Tomas Dobrocky (T)

Interventional and Diagnostic Neuroradiology, Bern, Switzerland.

David G Marcellus (DG)

Interventional and Diagnostic Neuroradiology, Stanford Medical Center, Palo Alto, CA, USA.

Jean Marc Olivot (JM)

Vascular Neurology, Stroke Department, Toulouse University Hospital, Toulouse, France.

Michel Piotin (M)

Interventional Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Jan Gralla (J)

Interventional and Diagnostic Neuroradiology, Bern, Switzerland.

Robert Fahed (R)

Interventional Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Max Wintermark (M)

Interventional and Diagnostic Neuroradiology, Stanford Medical Center, Palo Alto, CA, USA.

Jeremy J Heit (JJ)

Interventional and Diagnostic Neuroradiology, Stanford Medical Center, Palo Alto, CA, USA.

Christophe Cognard (C)

Interventional Neuroradiology Department, Hôpital Pierre-Paul Riquet, Toulouse University Hospital, Place du Dr Baylac, TSA 40 031, 31059, Toulouse Cedex 9, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH